Mediget Teshome, MD
Surgical Oncology · Los Angeles, CANPI 1699963678
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Endomagnetics Ltd at 50.9% of the total. 2025 is the largest year on record at $4,208, more than ten times the $163 reported in 2019.
Across 21 payments — averaging $437.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endomagnetics Ltd$5K
- AstraZeneca$4K
- Elucent Medical$202
- Hologic Sales And Service, LLC$193
- Tempus AI, Inc$108
- Intuitive Surgical$104
- plus $19 from 1 others
What the payments were for
- Consulting fees$3,75941%
- Travel & lodging$2,10523%
- Food & beverage$3,04933%
- Entertainment$2793%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endomagnetics Ltd | 11 | $4,675 |
| AstraZeneca | 2 | $3,891 |
| Elucent Medical | 3 | $202 |
| Hologic Sales And Service, LLC | 2 | $193 |
| Tempus AI, Inc | 1 | $108 |
| Intuitive Surgical | 1 | $104 |
| Medtronic | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$3,759
- Magseed$888
- Magtrace$835
- Da Vinci Surgical System$104
How this compares
$9,192 in reported general payments places this provider in the 75th percentile of 209 surgical oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Los Angeles
- Ronald HurstLos Angeles$76K
- James EconomouLos Angeles$27K
- Cristina FerroneLos Angeles$25K
- Lee ZuckermanLos Angeles$19K
- Scott UmLos Angeles$16K
- Lawrence MenendezLos Angeles$13K
- Sujit KulkarniLos Angeles$11K
- Joshua EllenhornLos Angeles$9K
- Jason CohenLos Angeles$8K
- Afshin BahadorSan Diego$701K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.